Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
A Phase II Study to Evaluate GFH375 in Patients With KRAS G12D Mutant Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT07026916. IPD Sharing: NO. Countries: 0. Publications: 0.
Sacituzumab Tirumotecan (Sac-TMT) Plus Bevacizumab in 3rd Generation EGFR-TKI Treated Advanced EGFR-mutant Nonsquamous NSCLC With Brain Metastasis
ClinicalTrials.gov study NCT07197008. IPD Sharing: NO. Countries: 0. Publications: 0.
CAPOX and Bevacizumab With or Without Primary Tumor Radiotherapy and Iparomlimab and Tuvonralimab as First-line Treatment for RAS-Mutant/MSS Metastatic Rectal Cancer
ClinicalTrials.gov study NCT07383285. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas
ClinicalTrials.gov study NCT04617002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Efficacy of L19TNF With Alkylating Chemotherapy for Patients With Recurrent IDH-mutant Astrocytoma or Oligodendroglioma
ClinicalTrials.gov study NCT07120984. IPD Sharing: NO. Countries: 0. Publications: 0.
Gossypol Acetate + FOLFIRI + Bev in mCRC With TP53-Mutant and LRPPRC Positive
ClinicalTrials.gov study NCT07337551. IPD Sharing: NO. Countries: 0. Publications: 0.
Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT07177092. IPD Sharing: NO. Countries: 0. Publications: 0.
MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03004105. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The Prediction Model of Avastin Plus Chemotherapy in Unresectable Ras Mutant CRLM Patients
ClinicalTrials.gov study NCT04525313. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation
ClinicalTrials.gov study NCT01836341. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma
ClinicalTrials.gov study NCT06264778. IPD Sharing: NO. Countries: 0. Publications: 0.
A Multi-omics Study of BRAF V600E Mutant Colorectal Cancer
ClinicalTrials.gov study NCT07007689. IPD Sharing: NO. Countries: 0. Publications: 0.
Firmonertinib 160 mg in Patients With EGFR-Mutant Advanced NSCLC Demonstrating SD After 8 Week Induction With Firmonertinib 80 mg
ClinicalTrials.gov study NCT07298148. IPD Sharing: NO. Countries: 0. Publications: 0.
Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases
ClinicalTrials.gov study NCT01646554. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Lapatinib With Trastuzumab in Treating Patients With HER2-Negative/HER2 Mutant Metastatic Breast Cancer
ClinicalTrials.gov study NCT01557764. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC
ClinicalTrials.gov study NCT04304638. IPD Sharing: NO. Countries: 0. Publications: 0.
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.
ClinicalTrials.gov study NCT06835179. IPD Sharing: NO. Countries: 0. Publications: 0.
ES-481 for Uncontrolled Glioma-Associated Epilepsy and Assessment for Potential Anti-Tumorigenic Effect in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Tumors
ClinicalTrials.gov study NCT04737174. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic Colorectal Cancer (FRU-RAS)
ClinicalTrials.gov study NCT07362836. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Sacituzumab Tirumotecan in Combination With Furmonertinib as Second-line Treatment for EGFR-mutant Advanced or Metastatic NSCLC After Failure of First-line Third-generation EGFR-TKI Therapy
ClinicalTrials.gov study NCT07193160. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.